Patents by Inventor Kevin James Taylor
Kevin James Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938317Abstract: Energy is transmitted to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.Type: GrantFiled: December 7, 2022Date of Patent: March 26, 2024Assignee: Galvanize Therapeutics, Inc.Inventors: William Sanford Krimsky, Paul Brian Friedrichs, Roman Turovskiy, Robert E. Neal, II, Jonathan Reuben Waldstreicher, Kevin James Taylor
-
Patent number: 11938454Abstract: The present disclosure is directed towards improved systems and methods for large-scale production of nanoparticles used for delivery of therapeutic material. The apparatus can be used to manufacture a wide array of nanoparticles containing therapeutic material including, but not limited to, lipid nanoparticles and polymer nanoparticles. In certain embodiments, continuous flow operation and parallelization of microfluidic mixers contribute to increased nanoparticle production volume.Type: GrantFiled: December 18, 2020Date of Patent: March 26, 2024Assignee: The University of British ColumbiaInventors: Euan Ramsay, Robert James Taylor, Timothy Leaver, Andre Wild, Kevin Ou, Colin Walsh
-
Publication number: 20230149706Abstract: Methods, systems and devices are provided which transmit energy to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.Type: ApplicationFiled: December 7, 2022Publication date: May 18, 2023Applicant: Galvanize Therapeutics, Inc.Inventors: William Sanford Krimsky, Paul Brian Friedrichs, Roman Turovskiy, Robert E. Neal, II, Jonathan Reuben Waldstreicher, Kevin James Taylor
-
Publication number: 20230082389Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: September 9, 2022Publication date: March 16, 2023Applicant: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Patent number: 11547851Abstract: Pulsed electric fields (PEFs) are transmitted to a body lumen or passageway in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.Type: GrantFiled: June 26, 2020Date of Patent: January 10, 2023Assignee: Galvanize Therapeutics, Inc.Inventors: William Sanford Krimsky, Paul Brian Friedrichs, Roman Turovskiy, Robert E. Neal, II, Jonathan Reuben Waldstreicher, Kevin James Taylor
-
Publication number: 20220395323Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: May 25, 2022Publication date: December 15, 2022Applicant: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Patent number: 11471208Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: June 26, 2020Date of Patent: October 18, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Patent number: 11369433Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: December 20, 2018Date of Patent: June 28, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Patent number: 11324543Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: March 26, 2021Date of Patent: May 10, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Publication number: 20210393327Abstract: Devices, systems and methods are provided for treating conditions of the heart, particularly the occurrence of arrhythmias. The devices, systems and methods deliver therapeutic energy to portions the heart to provide tissue modification, such as to the entrances to the pulmonary veins in the treatment of atrial fibrillation. Generally, the tissue modification systems include a specialized catheter, a high voltage waveform generator and at least one distinct energy delivery algorithm. Other embodiments include conventional ablation catheters and system components to enable use with a high voltage waveform generator. Example catheter designs include a variety of delivery types including focal delivery, “one-shot” delivery and various possible combinations. In some embodiments, energy is delivered in a monopolar fashion. However, it may be appreciated that a variety of other embodiments are also provided.Type: ApplicationFiled: September 3, 2021Publication date: December 23, 2021Applicant: Galary, Inc.Inventors: Curt Robert Eyster, Quim Castellvi, Timothy James Gundert, Robert E. Neal, II, Jonathan R. Waldstreicher, Isidro Gandionco, Steven D. Girouard, Vikramaditya Mediratta, Kevin James Taylor, Armaan G. Vachani, William S. Krimsky, Rajesh Pendekanti
-
Publication number: 20210236815Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, those within the respiratory tract, particularly the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The systems may be used to treat pathogens, such as bacteria and viruses, particularly coronaviruses.Type: ApplicationFiled: March 25, 2021Publication date: August 5, 2021Applicant: Galary, Inc.Inventors: Jonathan R. Waldstreicher, William S. Krimsky, Robert E. Neal, II, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20210236816Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: March 26, 2021Publication date: August 5, 2021Applicant: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long, Robert E. Neal, II
-
Publication number: 20210146126Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: June 26, 2020Publication date: May 20, 2021Applicant: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long, Robert E. Neal, II
-
Patent number: 10939958Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: June 10, 2020Date of Patent: March 9, 2021Assignee: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20200398048Abstract: Methods, systems and devices are provided which transmit energy to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.Type: ApplicationFiled: June 26, 2020Publication date: December 24, 2020Applicant: Galary, Inc.Inventors: William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Roman Turovskiy, Gary L. Long, Robert E. Neal, II, Jonathan Reuben Waldstreicher, Kevin James Taylor
-
Publication number: 20200323586Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: June 10, 2020Publication date: October 15, 2020Applicant: Galary, Inc.Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Patent number: 10702337Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: April 11, 2019Date of Patent: July 7, 2020Assignee: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20190231425Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: April 11, 2019Publication date: August 1, 2019Applicant: Gala Therapeutics, Inc.Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Publication number: 20190201089Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: December 20, 2018Publication date: July 4, 2019Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Publication number: 20090006130Abstract: A method of calculating a relative indicator of injury risk for a group of individuals, where injury risk is assessed across at least one risk category associated with an injury risk factor, the method being characterised by the steps of; receiving a plurality of risk values, where a single risk value is received for each individual of the group for each risk category considered, calculating a risk ratio for each possible risk value available for each risk category considered using the received risk values, calculating a category metric for each risk category considered using the risk ratios of each risk category, and calculating a relative indicator of injury risk for the group using a linear combination of the calculated category metrics.Type: ApplicationFiled: June 26, 2008Publication date: January 1, 2009Applicant: Wellnomics LimitedInventors: Kevin James Taylor, Robert van Nobelen